MobiHealth News October 18, 2019
The life science industry is making moves in the digital health space. In fact, within the last two years Sanofi, Novartis and GSK have all recently inked deals with digital health companies.
However, the relationship between pharma companies and digital health has not always been infallible. This week Novartis division Sandoz broke ties with its digital therapeutic partner Pear Therapeutics.
Yet, providers and pharma stakeholders continue to look at digital tools as a potential for the future. This week at the Connected Health Conference in Boston, Bob Coughlin, executive director of the Mass Biotech Council, and Dr. Joe Kvedar, VP of Connected Health at Partners, talked the future of digital in life sciences.
“About 70% of our...
Today's Sponsors
Today's Sponsor